Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Sees Significant Drop in Short Interest

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) was the target of a large decline in short interest during the month of June. As of June 15th, there was short interest totalling 19,400 shares, a decline of 33.1% from the May 31st total of 29,000 shares. Based on an average trading volume of 15,800 shares, the days-to-cover ratio is currently 1.2 days.

Cardio Diagnostics Trading Up 21.6 %

NASDAQ:CDIOW traded up $0.01 during midday trading on Friday, reaching $0.04. 1,430 shares of the company traded hands, compared to its average volume of 19,042. The company has a fifty day moving average price of $0.06 and a 200 day moving average price of $0.11. Cardio Diagnostics has a twelve month low of $0.03 and a twelve month high of $0.28.

About Cardio Diagnostics

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.